These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 23747733)

  • 41. Some comments on the lipoprotein micelle theory of drug action.
    HERVEY GR
    Kings Coll Hosp Gaz; 1946; 25(2):74-9. PubMed ID: 21002477
    [No Abstract]   [Full Text] [Related]  

  • 42. Role of Surface Charge of Nanoscale Ultrasound Contrast Agents in Complement Activation and Phagocytosis.
    Zhou J; Xiang H; Huang J; Zhong Y; Zhu X; Xu J; Lu Q; Gao B; Zhang H; Yang R; Luo Y; Yan F
    Int J Nanomedicine; 2022; 17():5933-5946. PubMed ID: 36506344
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Complement opsonization of nanoparticles: Differences between humans and preclinical species.
    Li Y; Wang G; Griffin L; Banda NK; Saba LM; Groman EV; Scheinman R; Moghimi SM; Simberg D
    J Control Release; 2021 Oct; 338():548-556. PubMed ID: 34481928
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Physiological and Pathological Factors Affecting Drug Delivery to the Brain by Nanoparticles.
    Islam Y; Leach AG; Smith J; Pluchino S; Coxon CR; Sivakumaran M; Downing J; Fatokun AA; Teixidò M; Ehtezazi T
    Adv Sci (Weinh); 2021 Jun; 8(11):e2002085. PubMed ID: 34105297
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nanoparticle-Induced Complement Activation: Implications for Cancer Nanomedicine.
    La-Beck NM; Islam MR; Markiewski MM
    Front Immunol; 2020; 11():603039. PubMed ID: 33488603
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Complement Inhibitors Block Complement C3 Opsonization and Improve Targeting Selectivity of Nanoparticles in Blood.
    Gaikwad H; Li Y; Gifford G; Groman E; Banda NK; Saba L; Scheinman R; Wang G; Simberg D
    Bioconjug Chem; 2020 Jul; 31(7):1844-1856. PubMed ID: 32598839
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Toxicity and immunogenicity concerns related to PEGylated-micelle carrier systems: a review.
    Shiraishi K; Yokoyama M
    Sci Technol Adv Mater; 2019; 20(1):324-336. PubMed ID: 31068982
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Interplay Between Blood Proteins, Complement, and Macrophages on Nanomedicine Performance and Responses.
    Moghimi SM; Simberg D; Skotland T; Yaghmur A; Hunter AC
    J Pharmacol Exp Ther; 2019 Sep; 370(3):581-592. PubMed ID: 30940695
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeting the mTOR Signaling Pathway Utilizing Nanoparticles: A Critical Overview.
    Lunova M; Smolková B; Lynnyk A; Uzhytchak M; Jirsa M; Kubinová Š; Dejneka A; Lunov O
    Cancers (Basel); 2019 Jan; 11(1):. PubMed ID: 30642006
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo.
    Chen F; Wang G; Griffin JI; Brenneman B; Banda NK; Holers VM; Backos DS; Wu L; Moghimi SM; Simberg D
    Nat Nanotechnol; 2017 May; 12(4):387-393. PubMed ID: 27992410
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activation of Human Complement System by Dextran-Coated Iron Oxide Nanoparticles Is Not Affected by Dextran/Fe Ratio, Hydroxyl Modifications, and Crosslinking.
    Wang G; Chen F; Banda NK; Holers VM; Wu L; Moghimi SM; Simberg D
    Front Immunol; 2016; 7():418. PubMed ID: 27777575
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of buprenorphine hydrochloride Pluronic(®) gel formulation in male C57BL/6NCrl mice.
    Blankenship-Paris TL; Dutton JW; Goulding DR; McGee CA; Kissling GE; Myers PH
    Lab Anim (NY); 2016 Sep; 45(10):370-9. PubMed ID: 27654688
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety of Nanoparticles in Medicine.
    Wolfram J; Zhu M; Yang Y; Shen J; Gentile E; Paolino D; Fresta M; Nie G; Chen C; Shen H; Ferrari M; Zhao Y
    Curr Drug Targets; 2015; 16(14):1671-81. PubMed ID: 26601723
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modulatory Role of Surface Coating of Superparamagnetic Iron Oxide Nanoworms in Complement Opsonization and Leukocyte Uptake.
    Inturi S; Wang G; Chen F; Banda NK; Holers VM; Wu L; Moghimi SM; Simberg D
    ACS Nano; 2015 Nov; 9(11):10758-68. PubMed ID: 26488074
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Properties and prospects of adjuvants in influenza vaccination - messy precipitates or blessed opportunities?
    Jalilian B; Christiansen SH; Einarsson HB; Pirozyan MR; Petersen E; Vorup-Jensen T
    Mol Cell Ther; 2013; 1():2. PubMed ID: 26056568
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mechanisms of complement activation by dextran-coated superparamagnetic iron oxide (SPIO) nanoworms in mouse versus human serum.
    Banda NK; Mehta G; Chao Y; Wang G; Inturi S; Fossati-Jimack L; Botto M; Wu L; Moghimi SM; Simberg D
    Part Fibre Toxicol; 2014 Nov; 11():64. PubMed ID: 25425420
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Complement monitoring of Pluronic 127 gel and micelles: suppression of copolymer-mediated complement activation by elevated serum levels of HDL, LDL, and apolipoproteins AI and B-100.
    Hamad I; Hunter AC; Moghimi SM
    J Control Release; 2013 Sep; 170(2):167-74. PubMed ID: 23747733
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Causative factors behind poloxamer 188 (Pluronic F68, Flocor)-induced complement activation in human sera. A protective role against poloxamer-mediated complement activation by elevated serum lipoprotein levels.
    Moghimi SM; Hunter AC; Dadswell CM; Savay S; Alving CR; Szebeni J
    Biochim Biophys Acta; 2004 Jun; 1689(2):103-13. PubMed ID: 15196591
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Surface-attached PEO in the form of activated Pluronic with immobilized factor H reduces both coagulation and complement activation in a whole-blood model.
    Andersson J; Bexborn F; Klinth J; Nilsson B; Ekdahl KN
    J Biomed Mater Res A; 2006 Jan; 76(1):25-34. PubMed ID: 16250010
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pluronic block copolymers inhibit low density lipoprotein self-association.
    Melnichenko AA; Aksenov DV; Myasoedova VA; Panasenko OM; Yaroslavov AA; Sobenin IA; Bobryshev YV; Orekhov AN
    Lipids; 2012 Oct; 47(10):995-1000. PubMed ID: 22797973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.